Biogenic Nanoparticles for Cancer Theranostics Micro and Nano Technologies Series
Coordonnateurs : Patra Chittaranjan, Ahmad Irshad, Ayaz Muhammad, Khalil Ali Talha, Mukherjee Sudip, Ovais Muhammad
Biogenic Nanoparticles for Cancer Theranostics outlines the synthesis of biogenic nanoparticles to become cancer theranostic agents. The book also discusses their cellular interaction and uptake, pharmacokinetics, biodistribution, drug delivery efficiency, and other biological effects. Additionally, the book explores the mechanism of their penetration in cancerous tissue, its clearance, and its metabolism. Moreover, the in vitro and in vivo toxicological effects of biogenic nanoparticles are discussed. This book is an important reference source for materials scientists and biomedical scientists who are looking to increase their understanding of how biogenic nanoparticles are being used for a range of cancer treatment types.
Metal nanoparticles have traditionally been synthesized by classical physico-chemical methods which have many drawbacks, such as high energy demand, high cost and potential ecotoxicity. As a result, the biosynthesis of metal nanoparticles is gaining increasing prominence. Biosynthesis approaches to metal nanoparticles are clean, safe, energy efficient and environment friendly.
1. Nanotechnology for cancer drug design, delivery, and theranostics applications
2. Biogenic nanoparticles: synthesis, mechanism, characterization, and applications
3. Phytonanotechnology: a greener approach for biomedical applications
4. Microbial enzymes–mediated biosynthesis of metal nanoparticles
5. Green nanotechnology: isolation of bioactive molecules and modified approach of biosynthesis
6. Green synthesis of inorganic nanoparticles and their cancer theranostics applications
7. Biosynthesized silver nanoparticles in cancer theranostics applications
8. Green-synthesized nanoparticles for fluorescence bioimaging and diagnostic applications
9. Bioinspired nanoparticles-based drug delivery systems for cancer theranostics
10. Mechanisms underlying the anticancer applications of biosynthesized nanoparticles
11. Progress, challenges, and future opportunities for green nanomaterials as cancer nanomedicine
Irshad Ahmad is Associate Professor of Life Sciences Department at King Fahd University of Petroleum & Minerals, Saudi Arabia. His research focuses in the area of green nanobiotechnology and cellular metabolics.
Muhammad Ayaz is a Lecturer at the Department of Pharmacy, University of Malakand, Pakistan. His research focuses on nanomaterials for drug delivery.
Ali Talha Khalil is an Assistant Professor (Molecular Biology), in the Department of Pathology, Lady Reading Hospital – Medical Teaching Institution, located in Peshawar, Pakistan. His research focuses on nanobiotechnological approaches to answer pressing challenges in health, environment and industry.
Sudip Mukherjee is a
- Explains the synthesis methods and applications of biogenic nanoparticles for cancer theranostics
- Outlines the distinctive features of biogenic nanoparticles that make them effective cancer treatment agents
- Assesses the major challenges of using biogenic nanoparticles on a mass scale
Date de parution : 05-2021
Ouvrage de 284 p.
19x23.3 cm
Thème de Biogenic Nanoparticles for Cancer Theranostics :
Mots-clés :
Cancer; Drug design and delivery; Nanomedicine; Nanotechnology; Theranostics; Applications; Biogenic; Eco-friendly; Nanoparticles; Biological activity; Biomedicine; Green synthesis; Biosynthesis; Enzymes; Microbes; Microgenic synthesis; Bioactive nanobiomaterials; Green nanotechnology; Isolated phy¬tochemicals; Secondary metabolites; Biomedical applications; Drug delivery; Green chemistry; Inorganic nanoparticles; Silver nanoparticles; Bio-imaging; Diagnosis; Fluorescence; Green nanoparticles; Imaging probes; NIR dye; Bioinspired nanoparticles; Biogenic nanoparticles; Cancer theranostics; Metal nanoparticles; Nanomedicines; Phytosynthesis